1
|
Lopes LC, Salas M, Osorio-de-Castro CGS, Leal LF, Doubova SV, Cañás M, Dreser A, Acosta A, Baldoni AO, de Cássia Bergamaschi C, Mota DM, Gómez-Galicia DL, Sepúlveda-Viveros D, Delgado EN, da Costa Lima E, Chandia FV, Ferre F, Marin GH, Olmos I, Zimmermann IR, Fulone I, Roldán-Saelzer J, Sánchez-Salgado JC, Castro-Pastrana LI, de Souza LJC, Beltrán MM, Silva MT, Mena MB, de França Fonteles MM, Urtasun MA, Mónica Tarapués MD, Patricia Granja Hernández MD, Medero N, Comoglio RH, Barberato-Filho S, Galvão TF, Luiza VL, Santa-Ana-Tellez Y, Tanta YR, Elseviers M. Data Sources for Drug Utilization Research in Latin American countries - a cross-national study: DASDUR-LATAM Study. Pharmacoepidemiol Drug Saf 2021; 31:343-352. [PMID: 34957616 DOI: 10.1002/pds.5404] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2021] [Revised: 12/17/2021] [Accepted: 12/20/2021] [Indexed: 11/10/2022]
Abstract
PURPOSE Drug utilization research (DUR) contributes to inform policymaking and to strengthen health systems. The availability of data sources is the first step for conducting DUR. However, documents that systematize these data sources in Latin American (LatAm) countries are not known. We compiled the potential data sources for DUR in the LatAm region. METHODS A network of DUR experts from nine LatAm countries was assembled and experts conducted: (i) a website search of the government, academic, and private health institutions; (ii) screening of eligible data sources, and (iii) liaising with national experts in pharmacoepidemiology (via an on-line survey). The data sources were characterized by accessibility, geographic granularity, setting, sector of the data, sources and type of the data. Descriptive analyses were performed. RESULTS We identified 125 data sources for DUR in nine LatAm countries. Thirty-eight (30%) of them were publicly and conveniently available; 89 (71%) were accessible with limitations, and 18 (14%) were not accessible or lacked clear rules for data access. From the 125 data sources, 76 (61%) were from the public sector only; 46 (37%) were from pharmacy records; 43 (34%) came from ambulatory settings and; 85 (68%) gave access to individual patient-level data. CONCLUSIONS Although multiple sources for DUR are available in LatAm countries, the accessibility is a major challenge. The procedures for accessing DUR data should be transparent, feasible, affordable and protocol-driven. This inventory could permit a comparison of drug utilization between countries identifying potential medication-related problems that need further exploration.
Collapse
Affiliation(s)
- Luciane C Lopes
- Pharmaceutical Science Graduate Course, Universidade de Sorocaba UNISO, Sao Paulo, Brazil.,Rodovia Raposo Tavares, Km 92, 5, Sorocaba, Sao Paulo, Brazil
| | - Maribel Salas
- Daiichi Sankyo, Inc., Address: 211 Mount Airy Road, 1A-453, Basking Ridge, New Jersey, USA.,CCEB/CPeRT., University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
| | - Claudia Garcia Serpa Osorio-de-Castro
- National School of Public Health, Oswaldo Cruz Foundation (Ministry of Health), Rio de Janeiro, Brazil.,Rua Leopoldo Bulhões, 1480, Manguinhos, Rio de Janeiro, RJ, Brazil
| | - Lisiane Freitas Leal
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University/Centre for Clinical Epidemiology - Lady Davis Institute, Montreal, Canada, 3755 Côte-Ste-Catherine Road, Pavillion H-485, Montreal, QC, Canada
| | - Svetlana V Doubova
- National Medical Center Siglo XXI, Mexico, Mexican Institute of Social Security, Mexico City (IMSS), Av Cuahutemos 330. México City, Mexico
| | - Martín Cañás
- Federación Médica de la Provincia de Buenos Aires (FEMEBA), Argentina, Calle 5 N° 473, La Plata, Argentina
| | - Anahi Dreser
- Centre for Health Systems Research, National Institute of Public Health, Mexico, Av. Universidad 655, Cuernavaca, Morelos, Mexico
| | - Angela Acosta
- University of Sao Paulo Department of Public Health, São Paulo, SP, Brazil
| | - Andre Oliveira Baldoni
- Universidade Federal de São João Del-Rei (UFSJ), Dvinópolis, Brazil, R. Sebastião Gonçalves Coelho, 400 - Chanadour, Divinópolis, MG, Brazil
| | - Cristiane de Cássia Bergamaschi
- Pharmaceutical Science Graduate Course, Universidade de Sorocaba UNISO, Sao Paulo, Brazil.,Rodovia Raposo Tavares, Km 92, 5, Sorocaba, Sao Paulo, Brazil
| | - Daniel Marques Mota
- Brazilian Health Regulatory Agency, Brasilia, Brazil.,Setor de Indústria e Abastecimento (SIA) - Trecho 5, Área Especial 57, Brasília, DF, Brazil
| | - Diana L Gómez-Galicia
- Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Mexico, Cuernavaca, Mexico
| | | | | | - Elisangela da Costa Lima
- School of Pharmacy, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.,Avenida Carlos Chagas Filho, 373, Cidade Universitária, Rio de Janeiro, RJ, Brazil
| | - Felipe Vera Chandia
- Unidad de Evaluación de Tecnologías en Salud, Centro de Investigación Clínica, Pontificia Universidad Católica de Chile., Chile, Avda. Libertador Bernando O'Higgins 340, Santiago, Chile
| | - Felipe Ferre
- Federal University of Minas Gerais - School of Medicine, Minas Gerais, Brazil, Av. Prof. Alfredo Balena, 190 - sala 503 / Belo Horizonte - MG zip 30130-100
| | - Gustavo H Marin
- Faculty of Medicine, National University of La Plata - CONICET, Argentina, Calle 60 y 120 (1900) La Plata, Argentina
| | - Ismael Olmos
- Servicios de Salud del Estado, Uruguay / Milán, Uruguay
| | - Ivan R Zimmermann
- Department of Public Health, University of Brasilia, Campus Darcy Ribeiro, Asa Norte, Brasilia, DF, Brazil
| | - Izabela Fulone
- Pharmaceutical Science Graduate Course, Universidade de Sorocaba UNISO, Sao Paulo, Brazil.,Rodovia Raposo Tavares, Km 92, 5, Sorocaba, Sao Paulo, Brazil
| | - Juan Roldán-Saelzer
- Instituto de Salud Publica de Chile, Santiago, Chile, Marathon 1000, Nunoa, Santiago, Chile
| | | | - Lucila I Castro-Pastrana
- Department of Chemical and Biological Sciences, Universidad de las Américas Puebla, Mexico.,ExHacienda de Santa Catarina Mártir s/n, 72810, San Andrés Cholula, Puebla, Mexico
| | - Luiz Jupiter Carneiro de Souza
- Oswaldo Cruz Foundation (Ministry of Health), Brasilia, Brazil.,Avenida L3 Norte, no number, Darcy Ribeiro University Campus (University of Brasília - UNB), Gleba A -ZIP Code: 70.904-130 - Brasília - DF, Brazil
| | | | - Marcus Tolentino Silva
- Pharmaceutical Science Graduate Course, Universidade de Sorocaba UNISO, Sao Paulo, Brazil.,Rodovia Raposo Tavares, Km 92, 5, Sorocaba, Sao Paulo, Brazil
| | - María Belén Mena
- Facultad de Ciencias Médicas, Universidad Central del Ecuador, Quito, Ecuador, Calle Sodiro e Iquique Quito-Ecuador
| | - Marta Maria de França Fonteles
- Universidade Federal do Ceará (UFC), Fortaleza, Ceará, Brazil, Rua Pastor Samuel Munguba, 1210, Rodolfo Teófilo, Fortaleza- Ceará, 60430-372, Brazil
| | - Martín A Urtasun
- Federación Médica de la Provincia de Buenos Aires (FEMEBA), Argentina, Calle 5 N° 473, La Plata, Argentina
| | - M D Mónica Tarapués
- Facultad de Ciencias Médicas, Universidad Central del Ecuador, Quito, Ecuador, Calle Sodiro e Iquique Quito-Ecuador
| | - M D Patricia Granja Hernández
- Hivos - Humanistic Organization for Social Change, Quito, Ecuador, Av. Amazonas 239 (entre 18 de septiembre y Jorge Washington) Quito - Ecuador
| | - Natalia Medero
- Servicios de Salud del Estado (ASSE), Montevedeo, Uruguay, Luis Alberto de Herrera 3326, Montevideo, Uruguay
| | - Raquel Herrera Comoglio
- Hospital Nacional de Clínicas, Pharmacovigilance Service, Buenos Aires, Argentina, Santa Rosa 1564, X5000 ETF, Córdoba, Argentina
| | - Silvio Barberato-Filho
- Pharmaceutical Science Graduate Course, University of Sorocaba, São Paulo, Brazil, Rodovia Raposo Tavares, Km 92,5, Sorocaba, São Paulo, Brazil
| | - Taís Freire Galvão
- Universidade Estadual de Campinas, Faculdade de Ciências Farmacêuticas, Campinas, Brazil, R. Cândido Portinari, 200 - Cidade Universitária Zeferino Vaz Campinas/SP 13083-871
| | - Vera Lucia Luiza
- National School of Public Health, Oswaldo Cruz Foundation (Ministry of Health), Rio de Janeiro, Brazil.,Rua Leopoldo Bulhões, 1480, Manguinhos, Rio de Janeiro, RJ, Brazil
| | - Yared Santa-Ana-Tellez
- Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Netherlands, David de Wiedgebouw, Universiteitsweg 99, Utrecht, Netherlands
| | - Yesenia Rodríguez Tanta
- Institute of Health and Technology Assessment and Research - Social Security of Peru (ESSALUD), Lima, Peru, Jirón Domingo Cueto 109, Jesús María 15072 - Lima, Peru
| | - Monique Elseviers
- Department of Clinical Pharmacology, University of Ghent, Belgium, Centre for Research and Innovation in Care, University of Antwerp, Belgium, Campus Drie Eiken, Building R - Office R. 214 Universiteitsplein 1 2610 WILRIJK (Antwerpen), Belgium
| |
Collapse
|